Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).
The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...
Acetylcysteine 100mg/mL, 200mg/mL; soln for inhalation; preservative-free. See literature for administration of aerosol. Nebulization-face mask, mouth piece, tracheostomy: 1–10mL of 20% soln or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results